Pacs [PACS] vs DaVita [DVA] Detailed Stock Comparison
Pacs
NYSE
Loading...
DaVita
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Pacs wins in 5 metrics, DaVita wins in 13 metrics, with 0 ties. DaVita appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pacs | DaVita | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 22.44 | 12.92 | DaVita |
| Price-to-Book Ratio | 3.65 | 6.41 | Pacs |
| Debt-to-Equity Ratio | 469.36 | 825.19 | Pacs |
| PEG Ratio | 7.65 | 5.51 | DaVita |
| EV/EBITDA | 19.01 | 8.70 | DaVita |
| Profit Margin (TTM) | 2.59% | 6.35% | DaVita |
| Operating Margin (TTM) | 0.07% | 15.70% | DaVita |
| EBITDA Margin (TTM) | 0.07% | 15.70% | DaVita |
| Return on Equity | 110.96% | 57.94% | Pacs |
| Return on Assets (TTM) | 3.21% | 7.15% | DaVita |
| Free Cash Flow (TTM) | $-109.11M | $1.47B | DaVita |
| 1-Year Return | -64.61% | -20.34% | DaVita |
| Price-to-Sales Ratio (TTM) | 0.60 | 0.71 | Pacs |
| Enterprise Value | $4.73B | $23.38B | DaVita |
| EV/Revenue Ratio | 1.33 | 1.78 | Pacs |
| Gross Profit Margin (TTM) | 15.67% | 33.08% | DaVita |
| Revenue per Share (TTM) | $27 | $164 | DaVita |
| Earnings per Share (Diluted) | $0.61 | $10.15 | DaVita |
| Beta (Stock Volatility) | N/A | 1.12 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Pacs vs DaVita Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pacs | 1.17% | 0.22% | 22.35% | 10.98% | 44.87% | 7.12% |
| DaVita | -2.30% | -1.88% | -4.74% | -10.27% | -12.60% | -14.47% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pacs | -64.61% | -42.29% | -42.29% | -42.29% | -42.29% | -42.29% |
| DaVita | -20.34% | 43.35% | 41.15% | 67.50% | 254.47% | 430.16% |
News Based Sentiment: Pacs vs DaVita
Pacs
News based Sentiment: MIXED
PACS Group is facing significant regulatory challenges with financial restatements and an audit investigation, but simultaneously projects strong financial performance and demonstrates robust operational metrics. The CFO resignation adds complexity, creating a mixed investment narrative.
DaVita
News based Sentiment: MIXED
October was a mixed month for DaVita, marked by a significant cybersecurity incident that created immediate operational and financial risks. However, positive analyst ratings, inclusion in Warren Buffett's portfolio, and indications of undervaluation suggest potential long-term value, creating a complex investment picture.
Performance & Financial Health Analysis: Pacs vs DaVita
| Metric | PACS | DVA |
|---|---|---|
| Market Information | ||
| Market Cap | $2.12B | $9.39B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 963,580 | 638,480 |
| 90 Day Avg. Volume | 1,329,400 | 791,187 |
| Last Close | $13.85 | $128.14 |
| 52 Week Range | $7.50 - $43.92 | $126.07 - $179.60 |
| % from 52W High | -68.47% | -28.65% |
| All-Time High | $43.92 (Oct 28, 2024) | $179.60 (Jan 27, 2025) |
| % from All-Time High | -68.47% | -28.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.29% | 0.06% |
| Quarterly Earnings Growth | N/A | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.06% |
| Operating Margin (TTM) | 0.00% | 0.16% |
| Return on Equity (TTM) | 1.11% | 0.58% |
| Debt to Equity (MRQ) | 469.36 | 825.19 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.75 | $-4.98 |
| Cash per Share (MRQ) | $0.48 | $10.34 |
| Operating Cash Flow (TTM) | $99.09M | $1.86B |
| Levered Free Cash Flow (TTM) | $1.62B | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Pacs vs DaVita
| Metric | PACS | DVA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 22.44 | 12.92 |
| Forward P/E | 7.65 | 11.64 |
| PEG Ratio | 7.65 | 5.51 |
| Price to Sales (TTM) | 0.60 | 0.71 |
| Price to Book (MRQ) | 3.65 | 6.41 |
| Market Capitalization | ||
| Market Capitalization | $2.12B | $9.39B |
| Enterprise Value | $4.73B | $23.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.33 | 1.78 |
| Enterprise to EBITDA | 19.01 | 8.70 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.12 |
| Book Value per Share (MRQ) | $3.75 | $-4.98 |
Financial Statements Comparison: Pacs vs DaVita
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PACS | DVA |
|---|---|---|
| Revenue/Sales | $981.85M | $3.22B |
| Cost of Goods Sold | $827.98M | $2.24B |
| Gross Profit | $153.87M | $983.87M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $710,000 | $433.33M |
| EBITDA | $5.58M | $597.84M |
| Pre-Tax Income | $-12.38M | $286.33M |
| Income Tax | $-1.47M | $54.12M |
| Net Income (Profit) | $-10.91M | $232.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PACS | DVA |
|---|---|---|
| Cash & Equivalents | $73.37M | $438.78M |
| Total Current Assets | $800.65M | $3.64B |
| Total Current Liabilities | $468.10M | $2.91B |
| Long-Term Debt | $2.54B | $11.72B |
| Total Shareholders Equity | $578.23M | $1.66B |
| Retained Earnings | $100.50M | $1.70B |
| Property, Plant & Equipment | $2.15B | $11.65B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PACS | DVA |
|---|---|---|
| Operating Cash Flow | $-33.46M | $287.94M |
| Capital Expenditures | $-111.48M | $-143.26M |
| Free Cash Flow | $-76.67M | $36.75M |
| Debt Repayment | $-465.05M | $-345.97M |
| Common Stock Repurchase | N/A | $-541.85M |
Short Interest & Institutional Ownership Analysis
| Metric | PACS | DVA |
|---|---|---|
| Shares Short | 3.19M | 7.51M |
| Short Ratio | 6.05 | 10.82 |
| Short % of Float | N/A | 0.21% |
| Average Daily Volume (10 Day) | 963,580 | 638,480 |
| Average Daily Volume (90 Day) | 1,329,400 | 791,187 |
| Shares Outstanding | 147.77M | 80.54M |
| Float Shares | 43.04M | 35.69M |
| % Held by Insiders | 0.72% | 0.50% |
| % Held by Institutions | 0.29% | 0.52% |
Dividend Analysis & Yield Comparison: Pacs vs DaVita
| Metric | PACS | DVA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |